The present invention generally relates to bodily implants and more particularly to bodily implants and their methods of delivery and placement within a body of a patient for the treatment of pelvic floor disorder.
Implant materials used to repair pelvic floor dysfunctions can be either biologic or synthetic to provide support to such as prolapsed organs. In some cases, both types of materials may have their disadvantages, for example, some biologic materials can be better integrated with tissues than synthetic materials, but may not provide the required strength to support the prolapsed organs. Additionally, some synthetic materials may result in long term complications such as mesh erosion, dyspareunia, and infection as opposed to biologic materials.
Therefore, some of the known implants are composed of several materials including synthetic materials as well as biologic materials rather than one material (either biologic or synthetic), wherein the synthetic material provides support and the biologic or biosynthetic material acts as an overlay material to ensure favorable tissue integration. Such implants may be ideally sterilized and packaged as combination devices such that a surgeon or an operator can take the implant out of the packaging right before implantation. As a consequence, in some cases, a concern in preparation of the combination devices arises, wherein the choice of the overlay biologic material dictates sterilization conditions. Thus, the overlay biologic material is limited to materials that can withstand sterilization and packaging conditions. As infection may be a concern, especially for transvaginal pelvic floor reconstruction implants, having limitations in packaging and sterilization conditions may not be desirable. In addition, in some cases, the implant may adhere to foreign materials during delivery trans-vaginally.
Therefore, in light of the above, there is a need for an implant and a suitable way to protect the implant during insertion and delivery to keep it clean and protected from any adhesion of foreign material.
In an embodiment, the invention discloses a medical device configured to be delivered and placed within a patient's body. The medical device includes an implant and a cover member. The implant is configured to be disposed within the patient's body. The implant includes a support member, a first arm member and a second arm member, an elongated first sleeve, and an elongated second sleeve. The support member includes a crescent shaped opening. The first arm member and the second arm member are coupled to the support member such that the support member extends between the two arm members. The elongated first sleeve is configured to enclose the first arm member and the elongated second sleeve is configured to enclose the second arm member. The cover member includes a cavity for enclosing a portion of the support member and a crescent shaped opening which is sized to be larger than the crescent shaped opening of the support member.
In an embodiment, the invention discloses a medical device configured to be delivered and placed within a patient's body. The medical device includes an implant and a cover member. The implant includes a support member, a first arm member and a second arm member, and an elongated sleeve. The support member is configured to be disposed within the patient's body and provide support to a bodily portion. The first arm member and the second arm member are coupled to the support member such that the support member extends between the two arm members. The elongated sleeve is configured to enclose the first arm member. The cover member is configured to enclose a portion of the support member. The cover member includes seams defined for tearing the cover member to facilitate removal of the cover member from the body into pieces.
In an embodiment, the invention discloses a method for placing a medical device in a patient's body. The method comprises creating a bodily access for delivery the medical device inside a patient's body. The medical device includes an implant with two arm members and a support member extending between the two arm members. The two arm members are enclosed in respective elongated sleeves and the support member is enclosed in a cover member. The method includes inserting the medical device inside the patient's body. The method further includes attaching the implant with a bodily tissue proximate the uterus. The method further includes removing the elongated sleeves. The method further includes removing the cover member from the patient's body, after attaching the implant, along a vaginal incision.
The invention and the following detailed description of certain embodiments thereof may be understood by reference to the following figures:
Detailed embodiments of the present invention are disclosed herein; however, it is to be understood that the disclosed embodiments are merely exemplary of the invention, which may be embodied in various forms. Therefore, specific structural and functional details disclosed herein are not to be interpreted as limiting, but merely as a basis for the claims and as a representative basis for teaching one skilled in the art to variously employ the present invention in virtually any appropriately detailed structure. Further, the terms and phrases used herein are not intended to be limiting, but rather to provide an understandable description of the invention.
The terms “a” or “an,” as used herein, are defined as one or more than one. The term “another,” as used herein, is defined as at least a second or more. The terms “including” and/or “having”, as used herein, are defined as comprising (i.e., open transition).
In general, the invention is directed to systems, methods, and devices for treating pelvic floor disorder. However, the invention may be equally employed for other soft tissue repair purposes such as hernia repair, repair of skeletal muscle, connective tissue repair, and the like. As described below in various illustrative embodiments, the invention provides systems, methods, and devices employing a medical device including an implant such that the implant is configured to be placed within a patient's body to support pelvic organs for the treatment of pelvic disorders such as pelvic prolapse and the like.
The term patient may be used hereafter for a person who benefits from the medical device or the methods disclosed in the present invention. For example, the patient may be a person whose body receives the medical device disclosed by the present invention in a surgical treatment. For example, in some embodiments, the patient may be a human female, human male, or any other mammal.
The terms proximal and distal described in relation to various devices, apparatuses, and components as discussed in the subsequent text of the present invention are referred to with a point of reference. The point of reference, as used in this description, is a perspective of an operator. The operator may be a surgeon, a physician, a nurse, a doctor, a technician, and the like, who may perform the procedure of delivery and placement of the bodily implants into the patient's body as described in the present invention. The term proximal refers to an area that is closest to the operator. The term distal refers to an area that is farthest from the operator.
The support member 106 can be of different shapes, sizes, and configurations depending on the indented use of the medical device 100 and location of its placement within the body of the patient. In some embodiments, the support member 106 can be substantially rectangular, square, oval, or elliptical. The support member 106 can be shaped and sized in conformation to the pelvic organ of the patient where it is attached or stitched. In accordance with some embodiments, the support member 106 may be configured to conform to the shape of the body location where the support member 106 is intended to be attached. In some embodiments, the support member 106 includes a crescent shaped profile at a top portion which is configured to contact the uterus. The crescent shape, such as in the shape of a crescent moon helps the support member 106 to conform to the shape of the uterus of a patient's body during attachment. In embodiments, the profile at the top portion of the support member 106 can be of different shapes, and can define an opening of different sizes, and configurations for providing effective support to the uterus.
In embodiments, the arm members 108 can include the two arm members—the first arm member 108A and the second arm member 108B. The arm members 108 are coupled to the support member 106 such that the support member 106 extends between the arm members 108A and 108B. The arm members 108A and 108B are configured to be attached to bodily locations. The bodily locations can be a sacrum or tissues proximate to the sacrum or vaginal walls or sacrospinous ligament. In some embodiments, the bodily locations can be one of the bones or tissues at or proximate to the back of the pelvis. In some embodiments, the bodily locations can include a hip bone. In some embodiments, the bodily locations can include a coccyx. In some embodiments, the bodily locations can include a sacrospinous ligament or any other body location so as to provide adequate support to the disordered organ of the pelvic floor with the use of the support member 106. In some other embodiments, a third, fourth or even more arm members (not shown) similar to the arm members 108A and 108B can also be provided.
The arm members 108A and 108B can be of various shapes, sizes, and configurations, depending on the indented use of the medical device 100 and the location of its placement within the body of the patient. In some embodiments, the arm members 108A and 108B can be substantially planar, cylindrical, tubular, vasiform, cannular, and the like.
In some embodiments, the length of the second arm member 108B is lesser than the length of the first arm member 108A. In some embodiments, the length of the second arm 108B member is greater than the length of the first arm member 108A. In some embodiments, the length of the first arm member 108A and the length of the second arm member 108B can be same. In some embodiments, the second arm member 108B has width equal to the width of the first arm member 108A. In other embodiments, the widths of the second arm member 108B and the first arm member 108A are different.
In some embodiments, the arm members 108 are integral portions of the support member 106 such that the support member 106, and the arm members 108A and 108B form a single integral structure. In other embodiments, the arm members 108A and 108B are removably or fixedly coupled to the support member 106 by an operator. In some cases, the arm members 108A and 108B can be coupled to the support member 106 at two symmetric locations on either side of a central axis of the support member 106. In some cases, the arm members 108A and 108B can be coupled to the support member 106 at two diametrically opposite locations. In other embodiments, the arm members 108A and 108B can be attached to the support member 106 asymmetrically.
In some embodiments, elements such as sutures, adhesives, bonding agents, mechanical fasteners (e.g. a medical grade plastic clip), and the like may be used to couple the arm members 108A and 108B to the support member 106.
In an embodiment, the support member 106 and the arm members 108A and 108B are made up of synthetic polymeric materials such as polypropylene, polyvinylidene fluoride, polyethylene terephthalate or other polymers. These members may also include a bioresorbable component, which allows for the reduction in implanted mass, over time. The support member 106 and arm members 108A and 108B can also be constructed from allograft materials such as fetal bovine dermis, porcine dermis, or intestinal submucosa. The material of the arm members 108A and 108B and the support member 106 and especially of the support member 106 provides strength to the implant 102; thus, providing effective support to the pelvic organs for treatment. In an embodiment, the support member 106 and the arm members 108A and 108B are made up of a mesh. An example of the mesh utilized in the implant is similar to Uphold™ Mesh Assembly developed by the Boston Scientific Corporation. The Uphold™ Mesh Assembly utilizes a polypropylene mesh. The mesh is made from uncoated monofilament polypropylene fiber, which is knitted into a macro-porous structure. In some embodiments, the mesh can have a specified weight. For example, in some embodiments, the mesh weight can be approximately between 15 g/cm2 to 35 g/cm2 (e.g., 20 g/cm2, 25 g/cm2, 30 g/cm2).
In some alternative embodiments, the support member 106 and the arm members 108A and 108B may also include a layer disposed over the support member 106 and the arm members 108A and 108B made up of a biological material or a biosynthetic material or a cadaveric tissue such as stem cells, natural xenograft material, collagen growth factors, and the like. This may facilitate favorable tissue integration.
In some embodiments, the implant is formed of a material that allows tissue in-growth after implantation. In some embodiments, the implant is made of a flexible material. In some embodiments, the implant is made of an elastic material. In some embodiments, the elastic and flexible synthetic material employed in the implant may allow stretching of the implant 102 without abdominal straining.
The implant 102 can be of various sizes (length, width, and thickness) depending on the intended use of a particular medical device 100 and the intended site of implantation. For example, the size of the support member 106 can depend on the size of the vaginal wall. Similarly, the size of the arm members 108 can have a length such that the support member 106 can be placed through and secured to the surrounding bodily tissues properly.
The cover member 104 is configured to enclose at least a portion of the support member 106. In some embodiments, the cover member 104 is configured to cover the entire support member 106. In some embodiments, the cover member 104 is configured to support a major or substantial part of the support member 106 as will be discussed later in conjunction with subsequent figures. In some embodiments, the cover member 104 is configured to enclose one or more arm members 108 in addition to the support member 106. For example, in some embodiments, the cover member 104 can enclose the first arm member 108A or the second arm member 108B or both. In some embodiments, even more arm members can be provided within the implant 102 such that the cover member 104 is configured to enclose even more arm members.
In embodiments, the cover member 104 may be removably or fixedly coupled to the support member 106 by an operator or surgeon at the time of surgery. In some embodiments, the cover member 104 may be temporarily attached to the support member 106 during delivery and placement of the implant 102 within the body and removed from the patient's body after surgery. In some embodiments, a solvent may be used to weaken and soften the cover member 104 such that the cover member 104 can be removed or pulled out after the implant 102 has been placed. Further, the solvent may have antimicrobial properties and may thus serve as an antimicrobial rinse. In some embodiments, the cover member 104 is permanently placed along with the implant 102 within the body of the patient. In such embodiments, the cover member 104, after implantation, may integrate with the tissue and erode over time. In such cases, the cover member 104 may facilitate initial healing of tissues.
In some embodiments, a physician may assemble the cover member 104 and the implant 102 by coupling such as by sling the implant 102 in the covering member. In some embodiments, the cover member 104 and the implant may alternatively be pre-assembled and the physician may use the pre-assembled implant 102. In an embodiment, the pre-assembled implant 102 and the cover member 104 can be packaged as a single kit. In another embodiment, the implant 102 and the cover member 104 are packaged separately.
In case of a removable cover member 104, in some embodiments, the cover member 104 may include seams defined for tearing the cover member 104 to facilitate removal of the cover member 104 into pieces from the body. In some embodiments, the seams are perforations or a series of openings or holes. In some embodiments, the seams may be provided longitudinally at several locations on the cover member 104 so as to cut the cover member 104 in several longitudinal pieces. In some embodiments, the seams may be provided horizontally along the circumference of the cover member 104 so as to tear the cover member 104 along the horizontal seams into several pieces. In some embodiments, one or several longitudinal and horizontal intersecting seams may be provided so as to tear the cover member 104 into several small pieces, facilitating removal of the small pieces from the body. In some embodiments, the cover member 104 may be scored or define a series of openings to facilitate the tearing of the cover member 104 into smaller pieces. In some embodiments, the cover member 104 may include a biodegradable portion or a portion that is configured to dissolve when contacted by bodily fluid to help facilitate the removal or tearing of the cover member 104.
In some embodiments, the cover member 104 is configured to keep the implant 102 sterile during and after delivery and implantation of the implant 102 within the patient's body. The cover member 104 keeps the implant 102 clean by avoiding any direct contact of a foreign material such as mucus, bacteria, particles, and the like on the implant 102. Thus, the foreign material adheres to the cover member 104 only during passage through the bodily tissues. In some embodiments, the cover member 104 may minimize the implant 102 folding during implantation.
The cover member 104 can be of different shapes, sizes, and configurations, depending on the indented use of the medical device 100 and the location of its placement within the body of the patient. In some embodiments, the cover member 104 can be substantially rectangular, square, oval, or elliptical. The cover member 104 can be shaped and sized in conformation to the support member 106 and the arm members 108A and 108B that it is configured to enclose. In accordance with some embodiments, for example, the cover member 104 may be configured to conform to the shape of the support member 106 of the implant 102. In some examples, the cover member 104 may be configured in a pouch shape or like an envelope having a cavity or such that the support member 106 can be retained within the cavity of the pouch shaped cover member 104. In some embodiments, the cover member 104 can include a portion that is substantially cylindrical, tubular, vasiform, cannular, or of any other shape to conform to the shape of the arm members 108A and 108B.
In some embodiments, the cover member 104 may include an opening or a cut out at the top of the cover member 104. The opening at the top of the cover member 104 can be of different shapes, sizes, including but not limited to a crescent shaped opening, rectangular opening, triangular opening, circular opening or of any other shape. The opening at the top of the cover member 104 may be greater than the opening at the top of the support member 106. This avoids, at times undesirable, suturing or attachment of the cover member 104 with the bodily tissues while suturing and attaching the support member 106 with the bodily tissues. The operator can thus find enough space around the opening of the support member 106 to pass threads or sutures in and out of the support member 106 without threading the suture through the cover member 104.
In an embodiment, the cover member 104 may be made up of synthetic materials such as plastic, polypropylene mesh, polymers, and other plastic materials (including, but not limited to, synthetic polymeric materials such as polypropylene, polyvinylidene fluoride, polyethylene terephthalate or other polymers). In some embodiments, the cover member 104 is made of a synthetic polymeric impermeable sheet. Some examples of polymeric materials utilized in the cover member 104 can be such as block polymers such as Styrene Ethylene Butadiene Styrene (SIBS), Poly(styrene-butadiene-styrene) (SBS), Polycaprolactone (PCl), Polylactic Acid (PLA) and the like, polyesters, polyurethanes, polylactide, polycaprolactones, hyaluronic acid-based material, biosynthesized cellulose and their copolymers, and the like. In some embodiments, the cover member 104 can be made from a biological material or a biosynthetic material or a cadaveric tissue such as stem cells, natural xenograft material, collagen growth factors, and the like.
In an embodiment, the cover member 104 can be made of a biocompatible material. In addition, to biocompatibility, the material of the cover member 104 can be selected so as to minimize mesh folding at implantation. In an embodiment, the cover member 104 can be made of a material that integrates with tissues and erodes over time after implantation, enabling appropriate healing. For example, in some embodiments, the cover member 104 can be made of hyaluronic acid. In such cases, the implant 102 can be packaged separately from the cover member 104, in some embodiments. After implantation, the hyaluronic acid-based cover member 104 integrates with tissues and erodes over time, and the implant 102 provides the required support. Also, by placing the cover member 104 around the implant 102, the implant 102 can be made lighter, with such as smaller diameter filaments, larger pores or both such that there is more support due to a rigid material during healing than after the implant 102 is absorbed. In this way, the support member 106 becomes more conformable and adapts more readily to natural motions in the pelvic floor. In accordance with some other embodiments, the cover member 104 can be made of materials other than hyaluronic acid that can provide required properties as discussed above, without limitations.
Additionally, the cover member 104 may be coated, impregnated, loaded or formed with one or more materials such as drugs, proteins, antibiotics, growth factors or other active compounds to be eluted to an adjacent tissue, in accordance with several other embodiments.
In some embodiments, chemical bioadhesives such as starch, epoxies, and the like may be used to couple the cover member 104 to the implant 102. In other embodiments, elements such as sutures, adhesives, bonding agents, mechanical fasteners (e.g. a medical grade plastic clip), and the like may be used to couple the cover member 104 to the implant 102. In some embodiments, the cover member 104 is made of a flexible material. In some embodiments, the cover member 104 is made of an elastic material. In some embodiments, the coupling element, such as the adhesive, may be configured to biodegrade or dissolve when contacted by bodily fluid to help facilitate the removal of the cover member 104.
In some embodiments, the cover member 104 fits tightly or snugly over the implant 102. For example, in some embodiments, the cover member 104 may define a cavity that is substantially the same size as the implant 102. In some embodiments, the cover member 104 fits loosely over the implant 102. For example, in some embodiments, the cover member 104 defines a cavity that is larger than the implant 102.
In some embodiments, the cover member 104 is porous. In some embodiments, the cover member 104 may include an antibiotic or antimicrobials. In some embodiments, the cover member 104 includes a polymer mesh. In some embodiments, the cover member 104 includes or is formed by a woven or non-woven mesh material.
The support member 206 is configured to be disposed within a patient's body and provide support to the bodily portion. In some embodiments, the bodily portion is a pelvic organ of the patient, such as a uterus of the patient.
The support member 206 includes a crescent shaped profile 212 at a top portion which is configured to contact the uterus. The crescent shape, such as in the shape of a crescent moon helps the support member 206 to conform to the shape of the uterus (or a neck of the uterus) of a patient's body during attachment. The crescent shaped profile defines an opening 212. The opening 212 facilitates the support member 206 to conform to the shape of the uterus or bodily portion where it is placed. A shown, the opening has a crescent shape. In some other embodiments, the opening 212 can have any other shape.
The implant 102 includes two arm members referred to as a first arm member 208A and a second arm member 208B (hereafter collectively referred to as arm members 208A and 208B interchangeably). The arm members 208A and 208B are coupled to the support member 206 such that the support member 206 extends between the arm members 208A and 208B. The arm members 208A and 208B are configured to be attached around the bodily location as discussed with respect to the device of
The arm members 208A and 208B can be of various different shapes, sizes, and configurations as discussed in
As shown, the first arm member 208A and the second arm member 208B can be coupled to the support member 206 at two symmetric locations on either side of a central axis A1 of the support member 206. In other cases, however, the first arm member 208A and the second arm member 208B can be coupled to the support member 206 at asymmetric locations.
In an embodiment, the support member 206 and the arm members 208A and 208B are made up of synthetic materials. Exemplary synthetic materials are discussed in conjunction with
In some embodiments, the support member 106 and the arm members 108A and 108B include a mesh body that may be made up of a biological material or a biosynthetic material or a cadaveric tissue. Exemplary cadaveric tissue is discussed in conjunction with
In some embodiments, the support member 206 and the first arm member 208A and the second arm member 208B are formed of a material that allows tissue in-growth after implantation. Various types of materials that can be employed to manufacture the implant have been described in conjunction with
The cover member 302 is configured to keep the implant 202 sterile during and after delivery and implantation of the implant 202 within the patient's body.
The cover member 302 as illustrated in
In some embodiments, the cover member 302 may include an opening 304 at the top of the cover member 302. The opening 304 at the top of the cover member 302 can be of different shapes, sizes, including but not limited to a crescent shaped opening, rectangular opening, triangular opening, circular opening or of any other shape. The opening at the top of the cover member 302 may be greater in size than the opening at the top of the support member 206. This avoids, at times undesirable, suturing or attachment of the cover member 302 with the bodily tissues while suturing and attaching the support member 206 with the bodily tissues. The operator can thus find enough space around the opening 212 of the support member 206 to pass threads or sutures in and out of the support member 206 without threading the suture through the cover member 302. In accordance with the illustrated embodiment two openings 304 are disclosed that are provided diametrically opposite. In some other cases, the cover member may include only one or more than two such openings. In an embodiment, the cover member 302 is made up of synthetic materials such as plastic, polypropylene, polymers, and other plastic materials. Exemplary polymeric materials are discussed in conjunction with
Additionally, the cover member 302 may be coated, impregnated, loaded or formed with one or more materials such as drugs, proteins, antibiotics, growth factors or other active compounds to be eluted to an adjacent tissue, in accordance with several embodiments as discussed in
In some embodiments, the arm member 208A and the support member 206 can be integral parts of a single component or implant. In some embodiments, the arm member 208A is removably attached to the support member 206. In such case, the arm members 208 can be coupled to the support member 206 with the use of such as a suture, in some embodiments. For example, the first arm member 208A can be coupled to the support member 206 with the use of a first suture and the second arm member 208B can be coupled to the support member with the use of a second suture. The first arm member 208A and the second arm member 208B can be configured to be decoupled from the support member 206 by cutting the first suture and the second suture, respectively. In some embodiments, a single suture may be used to couple the support member with the two arm members 208A and 208B. In some embodiments, the suture 504 that is used to couple the sleeve 502 with the first arm member 208A can extend further below to the support member 206 to couple the first arm member 208A to the support member 206.
The sleeve 1220 is secured to the first portion 1230 of the implant 1240 with a suture 1242. As shown in
The suture 1242 is coupled to and extends distally from the dilator 1210. Alternatively, a separate leader suture (separate from the suture 1242) can be used. A trocar needle 1246 is coupled to a distal end of the leader suture portion 1242 as shown in
In the illustrated embodiment, a set of tacks or heat welds 1225 (four tacks or heat welds 1225 are shown, but other quantities can be used) are disposed between two strands of the looped suture 1242 and near a distal end of the sleeve 1220. The set of tacks 1225 couple a top wall and a bottom wall of the sleeve 1220 together, and maintain separation of the strands of the looped suture 1242 within the sleeve 1220. A second set of tacks or welds 1223 can be used to lightly secure the implant 1240 to the sleeve 1220. The separation of the strands of the suture 1242 enables or helps facilitate a cut to be made through a portion of the sleeve 1220 and only a single strand of the looped suture 1242 at, for example, location B, to remove the sleeve 1220 from the implant 1240 after being implanted within a pelvic region. Using a set or group of small tacks or welds (rather than a single large tack) can help maintain flexibility of the implant 1240 during delivery into a pelvic region where it may need to fold or bend during insertion.
Referring to
In other embodiments, a tack weld or a heat weld (or a plurality of such welds) between the cover member and the support member may be used to temporarily couple the cover member to the support member. In some embodiments, a tack or heat weld is a coupling of a portion of the cover member with a portion of the support member by heating or otherwise melting a portion of at least one of the cover member and support member to weld or fuse the items together. The tack weld or heat weld may be configured to be released by pulling or forcing the cover member in a direction away from the support member. In such embodiments, the tack weld or heat weld would be configured to hold the cover member in place during delivery of the support member, but would allow the cover member to be removed without disrupting the position of the support member once the support member is correctly placed within the body of the patient. In yet other embodiments, an adhesive is used to couple a portion or portions of the cover member to the support member.
In accordance with another embodiment, as shown in
While, decoupling the cover member 302 from the support member 206, any of the bundles of suture ends can be cut and pulled to remove the cover member 302 from the support member 206.
In accordance with still another embodiment, as shown in
In some embodiments, the sutures 602A-602E used for coupling the implant 202 with the cover member 302 may be interwoven with the implant 202 to keep them flat such that the sutures can be removed after the implant 202 has been placed within the bodily tissues. The weaving pattern and pressure points for the sutures 602A-602C are selected such that during pulling of one side of a suture or one of the sets or bundles of the sutures 602A-602C, the remaining sutures may hold the implant 202 flat against the bodily tissues. To ensure that the scaffold remains flat at the time when sutures are pulled out, the sutures are weaved through the scaffold horizontally or vertically such that each suture may be pulled in one of three directions at time of removal: left, right, or down. When the sutures are pulled (by pulling at them simultaneously as a bundle), there is always at least one of the sutures being pulled in one of the three directions at the same time; by doing so, the forces on the mesh are cancelled out and the mesh remains flat while sutures are being pulled. For example, 602C and 602E are woven horizontally in the mesh and 602D is woven vertically through the mesh. By pulling these sutures at the same time the pulling force on the mesh is experienced in all three directions (and in addition, the mesh is being held at the top by attachments to ligands), so the mesh is not pulled in any particular direction more than the other at any point in time while the envelope is being removed, this way the mesh stays flat during removal.
In an embodiment, the size of the crescent shaped opening 304 of the cover member 302 is larger than the size of the crescent shaped opening 212 of the support member 206. Therefore, the cover member 302 does not cover the opening 212 of the support member 206 and a portion of the support member 206 adjacent the opening 212. This provides sufficient area (adjacent the opening 212 on the support member 206) to place sutures for attaching the support member 206 with the body tissues without the sutures placed through the cover member 302.
In some embodiments, the arm member 208A, and/or the support member 206 is also coupled to the sleeve 502 by the suture 504 such that the suture 504 can be pulled out to decouple the sleeve 502 from the support member 206 and the arm member 208A. After implantation of the support member 206 inside patient's body, the cover member 302 and the sleeve 502 are removed. In some embodiments, the cover member 302 can be removed through a vaginal incision and the sleeve 502 can be removed through the vaginal incision or an abdominal incision.
Referring to
In some embodiments, the cover member 702 may be temporarily attached to the support member 206 during delivery and placement of the implant 202 within the body and removed from the patient's body after surgery. In an embodiment, as shown in
As illustrated in
Referring now to
The method 900 includes creating a bodily access for delivery of the medical device inside a patient's body at step 902. In an embodiment, the access is created abdominally. In another embodiment, the access is created trans-vaginally. In accordance with various embodiments, an operator/surgeon may make incisions laproscopically, laprotomically, or in any other manner to create the required access to the vagina 802. In an embodiment, the implant 202 can be delivered and placed using an approach such as abdominal or laparoscopic sacrocolpopexy. Once the access to the vagina 802 is created, the medical device including the implant 202 and the covering member 302 is inserted into the patient's body at step 904.
In some embodiments, the method may further include attaching the implant 202 with a bodily tissue at step 906. The implant 202 can be attached with the bodily tissue such as through sutures or staples or using other means or elements. In embodiments, the implant 202 can be attached or stitched to the bodily tissues to provide support to a bodily portion. In some embodiments, the bodily portion is a pelvic organ of the patient such that the pelvic organ is supported by the support member 206. In other embodiments, the bodily portion is any other disordered organ of the patient such that the support member 206 is configured to support the disordered organ.
As discussed in conjunction with
In some embodiments, the implant may be coupled to the elongated sleeves such as 502 and 604 such as with the use of sutures as discussed above. In such cases, the method may include cutting the sutures for decoupling and removing the elongated sleeves 502 and 604 along such as an abdominal incision or a vaginal incision at step 908.
In some embodiments, the method further includes removing the cover member 302 from the patient's body after suturing of the implant 202 at step 910 such as through the vaginal incision. In some embodiments, the cover member 302 may be temporarily attached to the support member 206 during delivery and placement of the implant 202 within the body and removed from the patient's body after surgery. In some embodiments, the cover member 302 is sutured with the implant 202 using at least one suture. The method, in such cases, further comprises decoupling the cover member 302 from the implant 202 by cutting the suture. In some embodiments, a solvent may be used to weaken and soften the cover member 302 such that the cover member 302 can be removed or pulled out after the implant 202 has been sutured in place. As an exemplary scenario, the cover member 302 may include seams defined for tearing the cover member 302 to facilitate removal of the cover member 302 from the body as illustrated in
In some embodiments, a medical device configured to be delivered within a patient's body includes an implant and a cover member. The implant is configured to be disposed within the patient's body and includes a support member including a crescent shaped opening; a first arm member and a second arm member coupled to the support member such that the support member extends between the two arm members; an elongated first sleeve configured to enclose the first arm member; and an elongated second sleeve configured to enclose the second arm member. The cover member includes a cavity for enclosing a portion of the support member. The cover member includes a crescent shaped opening sized to be larger than the crescent shaped opening of the support member.
In some embodiments, the implant is configured for use in the treatment of pelvic floor disorders, the bodily portion being a pelvic organ supported by the support member. In some embodiments, the support member and the first arm member are made of a synthetic material. In some embodiments, the cover member is made of a synthetic polymeric impermeable sheet. In some embodiments, the cover member is made from one of a biologic and hyaluronic acid-based material. In some embodiments, the cover member is removable. The cover member includes seams defined for tearing the cover member to facilitate removal of the cover member from the body.
In some embodiments, the device includes a first suture couples the first arm member with the first elongated sleeve. The first arm member is configured to be decoupled from the first sleeve by cutting the first suture. In some embodiments, the device includes a second suture coupling the second arm member with the second elongated sleeve. The second arm member is configured to be decoupled from the second elongated sleeve by cutting the second suture.
In some embodiments, the device includes at least one suture coupling the implant to the cover member such that the cover member is configured to decouple the implant upon cutting of the at least one suture after placement and fixation of the implant at the bodily location. In some embodiments, the cover member includes a solvent configured to weaken and soften the cover member so as to facilitate removal of the cover member upon placement and suturing of the implant, the solvent further including antimicrobial properties.
In some embodiments, the crescent shaped opening of the support member is configured to be placed adjacent a uterus of the patient and shaped to conform to the shape of the uterus or a neck of the uterus.
In some embodiments, a medical device is configured to be delivered within a patient's body and includes and implant and a cover member. The implant includes a support member configured to be disposed within the patient's body and provide support to a bodily portion; a first arm member and a second arm member coupled to the support member such that the support member extends between the two arm members; and an elongated sleeve configured to enclose the first arm member. The cover member is configured to enclose a portion of the support member. The cover member includes seams defined for tearing the cover member to facilitate removal of the cover member from the body. In some embodiments, the cover member is made of a synthetic polymeric material. In some embodiments, the cover member is made from one of a biologic and hyaluronic acid-based material. In some embodiments, the support member and the first arm member is made of a synthetic material. In some embodiments, the elongated sleeve is a first sleeve, and the medical device further includes a second elongated sleeve configured to enclose the second arm member of the implant. The first elongated sleeve and the second elongated sleeve have a shape different than a shape of the cover member.
In some embodiments, a method for placing a medical device in a patient's body includes creating a bodily access for delivery the medical device inside a patient's body, the medical device including an implant with two arm members and a support member extending between the two arm members, wherein the two arm members are enclosed in respective elongated sleeves and the support member is enclosed in a cover member; inserting the medical device inside the patient's body; attaching the implant with a bodily tissue proximate the uterus; removing the elongated sleeves; and removing the cover member from the patient's body, after attaching the implant, along a vaginal incision.
In some embodiments, the support member and the two arm members are made of synthetic material. In some embodiments, the cover member is sutured with the implant using a suture, and the method includes decoupling the cover member from the implant by cutting the suture. In some embodiments, the elongated sleeves are coupled to the support member with the use of a suture, and the method includes cutting the suture for decoupling the elongated sleeves from the support member.
While the invention has been disclosed in connection with the preferred embodiments shown and described in detail, various modifications and improvements thereon will become readily apparent to those skilled in the art. Accordingly, the spirit and scope of the present invention is not to be limited by the foregoing examples, but it is to be understood in the broadest sense allowable by law.
This application is a Nonprovisional of, and claims priority to, U.S. Patent Application No. 61/777,211, filed on Mar. 12, 2013, entitled “A MEDICAL DEVICE FOR PELVIC FLOOR REPAIR AND METHOD OF DELIVERING THE MEDICAL DEVICE”, which is incorporated by reference herein in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
2687131 | Raiche | Aug 1954 | A |
3123077 | Alcamo | Mar 1964 | A |
4083369 | Sinnreich | Apr 1978 | A |
4324331 | Ignasiak | Apr 1982 | A |
4792336 | Hlavacek et al. | Dec 1988 | A |
4919667 | Richmond | Apr 1990 | A |
4998912 | Scarbrough et al. | Mar 1991 | A |
5013292 | Lemay | May 1991 | A |
5082112 | Dunklee | Jan 1992 | A |
5112344 | Petros | May 1992 | A |
5149329 | Richardson | Sep 1992 | A |
5217466 | Hasson | Jun 1993 | A |
5217486 | Rice et al. | Jun 1993 | A |
5217494 | Coggins et al. | Jun 1993 | A |
5263969 | Phillips | Nov 1993 | A |
5356432 | Rutkow et al. | Oct 1994 | A |
5362294 | Seitzinger | Nov 1994 | A |
5383905 | Golds et al. | Jan 1995 | A |
5405359 | Pierce | Apr 1995 | A |
5425747 | Brotz | Jun 1995 | A |
5451235 | Lock et al. | Sep 1995 | A |
5458609 | Gordon et al. | Oct 1995 | A |
5458636 | Brancato | Oct 1995 | A |
5485917 | Early | Jan 1996 | A |
5527341 | Gogolewski et al. | Jun 1996 | A |
5534008 | Acksel | Jul 1996 | A |
5540704 | Gordon et al. | Jul 1996 | A |
5562689 | Green et al. | Oct 1996 | A |
5569283 | Green et al. | Oct 1996 | A |
5578044 | Gordon et al. | Nov 1996 | A |
5584859 | Brotz | Dec 1996 | A |
5611515 | Benderev et al. | Mar 1997 | A |
5643311 | Smith et al. | Jul 1997 | A |
5662664 | Gordon et al. | Sep 1997 | A |
5683402 | Cosgrove et al. | Nov 1997 | A |
5700272 | Gordon et al. | Dec 1997 | A |
5702397 | Goble et al. | Dec 1997 | A |
5713910 | Gordon et al. | Feb 1998 | A |
5720761 | Kaali | Feb 1998 | A |
5741277 | Gordon et al. | Apr 1998 | A |
5741279 | Gordon et al. | Apr 1998 | A |
5741299 | Rudt | Apr 1998 | A |
5840011 | Landgrebe et al. | Nov 1998 | A |
5871488 | Tovey et al. | Feb 1999 | A |
5899909 | Claren et al. | May 1999 | A |
5922826 | Kuze et al. | Jul 1999 | A |
5931855 | Buncke | Aug 1999 | A |
5948001 | Larsen | Sep 1999 | A |
5976127 | Lax | Nov 1999 | A |
5988549 | Hitomi et al. | Nov 1999 | A |
6010447 | Kardjian et al. | Jan 2000 | A |
6012580 | Peters et al. | Jan 2000 | A |
6039686 | Kovac | Mar 2000 | A |
6042534 | Gellman et al. | Mar 2000 | A |
6042536 | Tihon et al. | Mar 2000 | A |
6042592 | Schmitt | Mar 2000 | A |
6044847 | Carter et al. | Apr 2000 | A |
6048351 | Gordon et al. | Apr 2000 | A |
6096051 | Kortenbach et al. | Aug 2000 | A |
6102921 | Zhu et al. | Aug 2000 | A |
6195646 | Grosh et al. | Feb 2001 | B1 |
6197036 | Tripp et al. | Mar 2001 | B1 |
6200330 | Benderev et al. | Mar 2001 | B1 |
6221005 | Bruckner et al. | Apr 2001 | B1 |
6224616 | Kugel | May 2001 | B1 |
6267772 | Mulhauser et al. | Jul 2001 | B1 |
6273852 | Lehe et al. | Aug 2001 | B1 |
6306079 | Trabucco | Oct 2001 | B1 |
6322492 | Kovac | Nov 2001 | B1 |
6328686 | Kovac | Dec 2001 | B1 |
6346111 | Gordon et al. | Feb 2002 | B1 |
6375662 | Schmitt | Apr 2002 | B1 |
6382214 | Raz et al. | May 2002 | B1 |
6406423 | Scetbon | Jun 2002 | B1 |
6454778 | Kortenbach | Sep 2002 | B2 |
6478727 | Scetbon | Nov 2002 | B2 |
6491703 | Ulmsten | Dec 2002 | B1 |
6502578 | Raz et al. | Jan 2003 | B2 |
6506190 | Walshe | Jan 2003 | B1 |
6530943 | Hoepffner et al. | Mar 2003 | B1 |
6544273 | Harari et al. | Apr 2003 | B1 |
6547800 | Foerster et al. | Apr 2003 | B2 |
6551329 | Kortenbach et al. | Apr 2003 | B1 |
6565580 | Beretta | May 2003 | B1 |
6575998 | Beyar | Jun 2003 | B2 |
6582443 | Cabak et al. | Jun 2003 | B2 |
6592515 | Thierfelder et al. | Jul 2003 | B2 |
6592610 | Beyar | Jul 2003 | B2 |
6595911 | Lovuolo | Jul 2003 | B2 |
6596001 | Stormby et al. | Jul 2003 | B2 |
6599235 | Kovac | Jul 2003 | B2 |
6599310 | Leung et al. | Jul 2003 | B2 |
6612977 | Staskin et al. | Sep 2003 | B2 |
6638209 | Landgrebe | Oct 2003 | B2 |
6638210 | Berger | Oct 2003 | B2 |
6638211 | Suslian et al. | Oct 2003 | B2 |
6638284 | Rousseau et al. | Oct 2003 | B1 |
6641524 | Kovac | Nov 2003 | B2 |
6641525 | Rocheleau et al. | Nov 2003 | B2 |
6648899 | Kalinski et al. | Nov 2003 | B2 |
6648921 | Anderson et al. | Nov 2003 | B2 |
6652450 | Neisz et al. | Nov 2003 | B2 |
6666817 | Li | Dec 2003 | B2 |
6669706 | Schmitt et al. | Dec 2003 | B2 |
6669735 | Pelissier | Dec 2003 | B1 |
6673010 | Skiba et al. | Jan 2004 | B2 |
6691711 | Raz et al. | Feb 2004 | B2 |
6695855 | Gaston | Feb 2004 | B1 |
6702827 | Lund et al. | Mar 2004 | B1 |
6730110 | Harari et al. | May 2004 | B1 |
6746455 | Beyar et al. | Jun 2004 | B2 |
6752814 | Gellman et al. | Jun 2004 | B2 |
6755781 | Gellman | Jun 2004 | B2 |
6808487 | Migliari | Oct 2004 | B2 |
6830052 | Carter et al. | Dec 2004 | B2 |
6848152 | Genova et al. | Feb 2005 | B2 |
6881184 | Zappala | Apr 2005 | B2 |
6890338 | Davis et al. | May 2005 | B1 |
6908425 | Luscombe | Jun 2005 | B2 |
6911003 | Anderson et al. | Jun 2005 | B2 |
6911034 | Nobles et al. | Jun 2005 | B2 |
6932759 | Kammerer et al. | Aug 2005 | B2 |
6936052 | Gellman et al. | Aug 2005 | B2 |
6936054 | Chu | Aug 2005 | B2 |
6936952 | Takamine | Aug 2005 | B2 |
6946003 | Wolowacz et al. | Sep 2005 | B1 |
6953428 | Gellman et al. | Oct 2005 | B2 |
6960160 | Browning | Nov 2005 | B2 |
6971986 | Staskin et al. | Dec 2005 | B2 |
6986780 | Rudnick et al. | Jan 2006 | B2 |
6991597 | Gellman et al. | Jan 2006 | B2 |
7011688 | Gryska et al. | Mar 2006 | B2 |
7025772 | Gellman et al. | Apr 2006 | B2 |
7048682 | Neisz et al. | May 2006 | B2 |
7056333 | Walshe | Jun 2006 | B2 |
7070556 | Anderson et al. | Jul 2006 | B2 |
7070558 | Gellman et al. | Jul 2006 | B2 |
7083568 | Neisz et al. | Aug 2006 | B2 |
7083637 | Tannhauser | Aug 2006 | B1 |
7090686 | Nobles et al. | Aug 2006 | B2 |
7094199 | Petros et al. | Aug 2006 | B2 |
7112171 | Rocheleau et al. | Sep 2006 | B2 |
7112210 | Ulmsten et al. | Sep 2006 | B2 |
7122039 | Chu | Oct 2006 | B2 |
7131943 | Kammerer | Nov 2006 | B2 |
7131944 | Jacquetin | Nov 2006 | B2 |
7198597 | Siegel et al. | Apr 2007 | B2 |
7204801 | Grocela | Apr 2007 | B2 |
7204802 | De Leval | Apr 2007 | B2 |
7223229 | Inman et al. | May 2007 | B2 |
7226407 | Kammerer et al. | Jun 2007 | B2 |
7226408 | Harai et al. | Jun 2007 | B2 |
7229453 | Anderson et al. | Jun 2007 | B2 |
7235043 | Gellman et al. | Jun 2007 | B2 |
7244260 | Koseki | Jul 2007 | B2 |
7244759 | Muller et al. | Jul 2007 | B2 |
7267645 | Anderson et al. | Sep 2007 | B2 |
7291104 | Neisz et al. | Nov 2007 | B2 |
7351197 | Montpetit et al. | Apr 2008 | B2 |
7361138 | Wagner et al. | Apr 2008 | B2 |
7364541 | Chu et al. | Apr 2008 | B2 |
7402133 | Chu et al. | Jul 2008 | B2 |
7413540 | Gellman et al. | Aug 2008 | B2 |
7527588 | Zaddem et al. | May 2009 | B2 |
7878970 | Goldberg | Feb 2011 | B2 |
20010049467 | Lehe et al. | Dec 2001 | A1 |
20020099259 | Anderson | Jul 2002 | A1 |
20020133236 | Rousseau | Sep 2002 | A1 |
20020151909 | Gellman et al. | Oct 2002 | A1 |
20020156489 | Gellman et al. | Oct 2002 | A1 |
20030023250 | Watschke et al. | Jan 2003 | A1 |
20030055313 | Anderson et al. | Mar 2003 | A1 |
20030078604 | Walshe et al. | Apr 2003 | A1 |
20030176762 | Kammerer | Sep 2003 | A1 |
20030191360 | Browning | Oct 2003 | A1 |
20030208208 | Chu | Nov 2003 | A1 |
20030220538 | Jacquetin | Nov 2003 | A1 |
20030225424 | Benderev | Dec 2003 | A1 |
20030233107 | Gellman et al. | Dec 2003 | A1 |
20030233108 | Gellman et al. | Dec 2003 | A1 |
20040015048 | Neisz et al. | Jan 2004 | A1 |
20040015177 | Chu | Jan 2004 | A1 |
20040034372 | Chu | Feb 2004 | A1 |
20040039246 | Gellman | Feb 2004 | A1 |
20040039453 | Anderson et al. | Feb 2004 | A1 |
20040059293 | Chu et al. | Mar 2004 | A1 |
20040068159 | Neisz et al. | Apr 2004 | A1 |
20040087970 | Chu et al. | May 2004 | A1 |
20040106847 | Benderev | Jun 2004 | A1 |
20040116944 | Chu et al. | Jun 2004 | A1 |
20040172048 | Browning | Sep 2004 | A1 |
20040181243 | Chu et al. | Sep 2004 | A1 |
20040186515 | Rosenblatt et al. | Sep 2004 | A1 |
20040225181 | Chu et al. | Nov 2004 | A1 |
20040231678 | Fierro et al. | Nov 2004 | A1 |
20040236356 | Rioux et al. | Nov 2004 | A1 |
20040249397 | Delorme et al. | Dec 2004 | A1 |
20040249473 | Delorme et al. | Dec 2004 | A1 |
20050027220 | Wagner | Feb 2005 | A1 |
20050038452 | Chu | Feb 2005 | A1 |
20050043580 | Watschke | Feb 2005 | A1 |
20050131391 | Chu et al. | Jun 2005 | A1 |
20050131392 | Chu et al. | Jun 2005 | A1 |
20050131393 | Chu et al. | Jun 2005 | A1 |
20050177022 | Chu et al. | Aug 2005 | A1 |
20050222589 | Chu | Oct 2005 | A1 |
20050222591 | Gingras et al. | Oct 2005 | A1 |
20050234291 | Gingras | Oct 2005 | A1 |
20050245787 | Cox et al. | Nov 2005 | A1 |
20050250977 | Montpetit et al. | Nov 2005 | A1 |
20050261545 | Gellman et al. | Nov 2005 | A1 |
20050261547 | Bouffier et al. | Nov 2005 | A1 |
20050278037 | Delorme et al. | Dec 2005 | A1 |
20060041263 | Chu et al. | Feb 2006 | A1 |
20060052801 | Dreyfuss et al. | Mar 2006 | A1 |
20060058575 | Zaddem et al. | Mar 2006 | A1 |
20060089525 | Mamo et al. | Apr 2006 | A1 |
20070173864 | Chu | Jul 2007 | A1 |
20090171143 | Chu | Jul 2009 | A1 |
20100256442 | Ogdahl | Oct 2010 | A1 |
20130030243 | Boden | Jan 2013 | A1 |
Number | Date | Country |
---|---|---|
10056169 | Jun 2002 | DE |
0088714 | Sep 1983 | EP |
0141589 | May 1985 | EP |
0299158 | Jan 1989 | EP |
0362146 | Apr 1990 | EP |
0412664 | Feb 1991 | EP |
0567130 | Oct 1993 | EP |
0774240 | May 1997 | EP |
1201189 | May 2002 | EP |
1508305 | Feb 2005 | EP |
1520554 | Apr 2005 | EP |
1609439 | Dec 2005 | EP |
2785521 | May 2000 | FR |
2852817 | Oct 2004 | FR |
2852818 | Oct 2004 | FR |
2871365 | Dec 2005 | FR |
670349 | Apr 1952 | GB |
06114067 | Apr 1994 | JP |
PA04008407 | Dec 2005 | MX |
9609796 | Apr 1996 | WO |
9639948 | Dec 1996 | WO |
9835632 | Aug 1998 | WO |
WO9835616 | Aug 1998 | WO |
9843545 | Oct 1998 | WO |
9937216 | Jul 1999 | WO |
0009039 | Feb 2000 | WO |
0074613 | Dec 2000 | WO |
0106951 | Feb 2001 | WO |
0152135 | Jul 2001 | WO |
0231681 | Apr 2002 | WO |
0232284 | Apr 2002 | WO |
0238079 | May 2002 | WO |
02062237 | Aug 2002 | WO |
02058563 | Aug 2002 | WO |
02078571 | Oct 2002 | WO |
03068107 | Aug 2003 | WO |
03073960 | Sep 2003 | WO |
03092546 | Nov 2003 | WO |
03096928 | Nov 2003 | WO |
03096929 | Nov 2003 | WO |
2004012626 | Feb 2004 | WO |
2004016196 | Feb 2004 | WO |
2004091442 | Oct 2004 | WO |
2004091443 | Oct 2004 | WO |
2005051204 | Jun 2005 | WO |
2005122721 | Dec 2005 | WO |
2005122954 | Dec 2005 | WO |
2006046950 | May 2006 | WO |
2007019374 | Feb 2007 | WO |
2007014240 | Feb 2007 | WO |
2007016698 | Feb 2007 | WO |
2007087132 | Aug 2007 | WO |
Entry |
---|
“Capio® Suture Capturing Devices”, Reach, Throw and Capture: One Step. One Device., Boston Scientific, 2005, 4 pages. |
“Transvaginal Suture Fixation to Cooper's Ligament for Sling Procedures”, Capio (TM) CL, “Transvaginal Suture Fixation to Cooper's Ligament for Sling Procedures,” Boston Scientific Microvasive product brochure, 2000, 4 pages. |
Leron, et al., “Sacrohysteropexy with synthetic mesh for the management of uterovaginal prolapse”, British Journal of Obstetrics and Gynaecology,108.3, 2001, 629-633. |
Mahdavi, et al., “A biodegradable and biocompatible gecko-inspired tissue adhesive”, PNAS, vol. 105, No. 7, Feb. 19, 2008, pp. 2307-2312. |
Number | Date | Country | |
---|---|---|---|
20140275753 A1 | Sep 2014 | US |
Number | Date | Country | |
---|---|---|---|
61777211 | Mar 2013 | US |